These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 19426421)

  • 1. Continuous renal replacement therapy in sepsis and multisystem organ failure.
    Joannidis M
    Semin Dial; 2009; 22(2):160-4. PubMed ID: 19426421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal supportive therapy for pediatric acute kidney injury in the setting of multiorgan dysfunction syndrome/sepsis.
    Brophy PD
    Semin Nephrol; 2008 Sep; 28(5):457-69. PubMed ID: 18790365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of crush syndrome complicated with multiple organ dysfunction syndrome using hybrid continuous renal replacement therapy.
    Wei Q; Baihai S; Ping F; Xiaolei C; Jing L; Rong Z
    Blood Purif; 2009; 28(3):175-80. PubMed ID: 19597302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.
    Lins RL; Elseviers MM; Van der Niepen P; Hoste E; Malbrain ML; Damas P; Devriendt J;
    Nephrol Dial Transplant; 2009 Feb; 24(2):512-8. PubMed ID: 18854418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous renal replacement therapies (CRRT)].
    Canepari G; Inguaggiato P; Gigliola G; Bainotti S; Formica M
    G Ital Nefrol; 2006; 23 Suppl 36():S30-7. PubMed ID: 17068727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal therapies in the treatment of sepsis: experience and promise.
    Fortenberry JD; Paden ML
    Semin Pediatr Infect Dis; 2006 Apr; 17(2):72-9. PubMed ID: 16822469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.
    Stegmayr BG; Banga R; Berggren L; Norda R; Rydvall A; Vikerfors T
    Crit Care Med; 2003 Jun; 31(6):1730-6. PubMed ID: 12794412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
    Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemofiltration during severe sepsis or multiorgan failure syndrome].
    Guenoun T; Journois D; Safran D
    Nephrologie; 1998; 19(2):83-8. PubMed ID: 9592778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal replacement therapy in acute kidney injury: which method to use in the intensive care unit?
    Davenport A
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):529-36. PubMed ID: 18580008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of pediatric renal replacement therapy in acute kidney injury.
    Goldstein SL
    Semin Dial; 2009; 22(2):180-4. PubMed ID: 19426425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 90-day mortality and the subsequent renal recovery in critically ill surgical patients requiring acute renal replacement therapy.
    Lin YF; Ko WJ; Chu TS; Chen YS; Wu VC; Chen YM; Wu MS; Chen YW; Tsai CW; Shiao CC; Li WY; Hu FC; Tsai PR; Tsai TJ; Wu KD;
    Am J Surg; 2009 Sep; 198(3):325-32. PubMed ID: 19716882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous renal replacement therapy: evolution in technology and current nomenclature.
    Ronco C; Bellomo R
    Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modalities of continuous renal replacement therapy: technical and clinical considerations.
    Cerdá J; Ronco C
    Semin Dial; 2009; 22(2):114-22. PubMed ID: 19426413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor necrosis factor-alpha kinetics during renal replacement therapy in patients with sepsis and multiple organ failure].
    Timokhov VS; Iakovleva II; Kalashnikova EA; Semenov VN
    Ter Arkh; 1997; 69(11):38-9. PubMed ID: 9483744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications for continuous renal function replacement therapy].
    Kes P; Ljutić D; Basić-Jukić N; Brunetta B
    Acta Med Croatica; 2003; 57(1):71-5. PubMed ID: 12876869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of continuous renal replacement therapy on drug therapy.
    Susla GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure.
    Kron J; Kron S; Wenkel R; Schuhmacher HU; Thieme U; Leimbach T; Kern H; Neumayer HH; Slowinski T
    Nephrol Dial Transplant; 2012 Jan; 27(1):146-52. PubMed ID: 21622989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis.
    Peng Y; Yuan Z; Li H
    Burns; 2005 Aug; 31(5):623-8. PubMed ID: 15975721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.